AI assistant
VECTION TECHNOLOGIES LTD — Capital/Financing Update 2025
Dec 14, 2025
66017_rns_2025-12-14_229bb2b5-2881-4936-81eb-e907ed42c894.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
15 December 2025 Australia
ASX RELEASE
TRADING UPDATE
Vection Technologies Ltd (ASX:VR1, OTC:VCTNY, FRA: S1X), ("Vection" or the "Company"), a leading provider of INTEGRATED XR[] and AI-powered digital transformation solutions, is pleased to provide a trading update to 12 December 2025, highlighting record quarter-to-date cash receipts, record pipeline update, continued operational momentum, growing contracted revenue visibility, and disciplined execution across core strategic initiatives (including deployment of the recent capital raising funds).
HIGHLIGHTS:
-
~$14m in cash receipts thus far in this quarter (to 12 December 2025).
-
Although the quarter has not yet ended, this cash receipts result is already ~180% more than the previous full quarter, and ~115% more on pcp (to the comparable full quarter a year ago).
-
These cash receipts Include the '$4m defence payment' as described by the FY25 Q4 Activity Report and Appendix 4C (released to the ASX on 31 July 2025).
-
The Total Contracted Value (TCV) across all programs is now ~$27m.
-
Total pipeline (3-year forward rolling)[1] in negotiation at 12 December 2025 is ~$50m (excluding TCV) across Defence, AI, Healthcare, Industrial and Retail transformation programs.
-
Launched capability strengthening the continued growth of defence, health care, retail and real estate markets.
-
The recent defence framework announcement[2] continues to progress In line with management's expectations, noting the Company has no defence exposure to the Middle East.
-
Capital deployment following the $21m capital raise is progressing as planned.
OVERVIEW
Strong Cash Collections: ~$14m to 12 December 2025
In the Company's historically weaker first half, Vection generated ~$14m in cash receipts during the quarter to date, which is already ~115% more on pcp (to the comparable full quarter a year ago). This result meets internal expectations and follows the company's usual seasonal trend, mainly influenced by the European business cycle. It highlights sustained demand across the Defence, AI, Healthcare, Industrial, and Retail sectors.
Total Contracted Value (TCV) Reaches ~$27m
At 12 December 2025, Vection’s Total Contracted Value (“TCV”) increased to ~$27m, supported by:
-
the multi-year NATO-aligned Defence framework,
-
expansion of Enterprise AI deployments,
-
growing Healthcare simulation programs,
-
Retail and Industrial transformation initiatives.
Record Pipeline (3-year forward) – ~$50m Across All Verticals
The Company’s total pipeline (3-year forward rolling)[1] under negotiation has grown to ~$50m (excluding TCV), reflecting the strongest commercial position in the Company’s history. The growth is driven by accelerating opportunities across Defence (Including the recently announced $22m deal[2] ), Utilities, Government, Healthcare, Retail, and APAC enterprise markets.
1 Total pipeline (3-year forward rolling) excludes work opportunities in negotiation that are deliverable beyond 3 years.
2 ASX Announcement “Vection secures $22m deal with NATO-approved partner”, 22 September 2025.
VECTION TECHNOLOGIES LTD
ASX:VR1; OTC:VCTNY | ACN: 614 814 041
WEBSITE
GLOBAL OFFICES
PERTH | SYDNEY | SAN FRANCISCO | MILAN | BOLOGNA | ROME | BARI | ABU DHABI | AHMEDABAD
REGISTERED OFFICE
Level 4, Building C, Garden Office Park, 355 Scarborough Beach Road, Osborne Park WA 6017 - Australia
Page 1
==> picture [596 x 93] intentionally omitted <==
Deployment of capital raise:
Following the successful $21m capital raise in October 2025, Vection has deployed capital in line with its previously communicated global growth roadmap:
-
Acceleration of defence, healthcare, retail and real estate teams
-
Accelerated AI Development
-
Balance Sheet Strength
-
Development & Integration of DXLabs and Monogic
-
US Market Scouting
The Company remains focused on growing revenue, increasing recurring revenue, converting multi-year frameworks, and speeding up product and market expansion in key verticals (both organically and inorganically).
AUTHORISATION:
This ASX release is authorised by the Board of Directors of Vection Technologies Limited.
ENDS
INVESTOR RELATIONS CONTACT DETAILS:
Gianmarco Biagi - Managing Director (Europe Based) Email: [email protected]
Cameron Petricevic - Independent, Non-Executive Director (Australia Based) Email: [email protected]
ABOUT VECTION TECHNOLOGIES:
Vection Technologies is a growing enterprise-focused company that helps businesses bridge the physical and digital worlds. We help organisations leverage their 3D data via powerful extended reality (XR) interfaces that foster collaboration and learning, grow sales and more.
Vection Technologies is listed on the Australian Securities Exchange (ASX) with ticker code VR1, and trades on the U.S. overthe-counter (OTC) markets under the symbol VCTNY and is also listed on Germany’s Frankfurt Stock Exchange under the ticker S1X.
For more information, please visit: www.vection-technologies.com
VECTION TECHNOLOGIES LTD
ASX:VR1; OTC:VCTNY | ACN: 614 814 041
WEBSITE
GLOBAL OFFICES
PERTH | SYDNEY | SAN FRANCISCO | MILAN | BOLOGNA | ROME | BARI | ABU DHABI | AHMEDABAD
REGISTERED OFFICE
Level 4, Building C, Garden Office Park, 355 Scarborough Beach Road, Osborne Park WA 6017 - Australia
Page 2
==> picture [596 x 93] intentionally omitted <==
FORWARD-LOOKING STATEMENTS:
Certain statements made in this release are forward-looking statements. These forward-looking statements are not historical facts but rather are based on Vection Technologies' current expectations, estimates and projections about the industry in which Vection Technologies operates, and beliefs and assumptions. Forward-looking statements can generally be identified by the use of forward-looking words such as 'anticipate', 'believe', 'expect', 'project', 'forecast', 'estimate', 'likely', 'intend', 'should', 'will', 'could', 'may', 'target', 'plan' and other similar expressions within the meaning of securities laws of applicable jurisdictions. Indications of, guidance, or outlook on future earnings, distributions, financial position, or performance are also forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the control of Vection Technologies, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions shareholders and prospective shareholders not to place undue reliance on these forwardlooking statements, which reflect the view of Vection Technologies only as of the date of this release. There can be no assurance that actual outcomes will not differ materially from these forward-looking statements.
The forward-looking statements made in this release relate only to events as of the date on which the statements are made. Vection Technologies has no obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date of this release except as required by law or by any appropriate regulatory authority.
VECTION TECHNOLOGIES LTD
ASX:VR1; OTC:VCTNY | ACN: 614 814 041
WEBSITE
GLOBAL OFFICES
PERTH | SYDNEY | SAN FRANCISCO | MILAN | BOLOGNA | ROME | BARI | ABU DHABI | AHMEDABAD
REGISTERED OFFICE
Level 4, Building C, Garden Office Park, 355 Scarborough Beach Road, Osborne Park WA 6017 - Australia
Page 3